1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione

C70H137N19O18 — CID 158361930

IUPAC1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione
SMILESCCC(O)Cn1c(=O)n(CC(O)CCCCCCNC)c(=O)n(CC(O)CNCCCCN)c1=O.CCC(O)Cn1c(=O)n(CC(O)CN(C)CCCN(CC)CC)c(=O)n(CC(O)CN(CC)CC)c1=O.CCC(O)Cn1c(=O)n(CC(O)CN2CCNCC2)c(=O)n(CC(O)CN2CCN(C)CC2)c1=O
InChIInChI=1S/C25H50N6O6.C23H46N6O6.C22H41N7O6/c1-7-20(32)17-29-23(35)30(18-21(33)15-26(6)13-12-14-27(8-2)9-3)25(37)31(24(29)36)19-22(34)16-28(10-4)11-5;1-3-18(30)15-27-21(33)28(16-19(31)10-6-4-5-8-12-25-2)23(35)29(22(27)34)17-20(32)14-26-13-9-7-11-24;1-3-17(30)14-27-20(33)28(15-18(31)12-25-6-4-23-5-7-25)22(35)29(21(27)34)16-19(32)13-26-10-8-24(2)9-11-26/h20-22,32-34H,7-19H2,1-6H3;18-20,25-26,30-32H,3-17,24H2,1-2H3;17-19,23,30-32H,3-16H2,1-2H3
InChIKeyGTORQOJOGDOPRF-UHFFFAOYSA-N
MW1532.98 g/mol
LogP-7.35
Rot. Bonds50

About 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione

1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione (PubChem CID 158361930) has the molecular formula C70H137N19O18 and a molecular weight of 1532.98 g/mol. Its IUPAC name is 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione.

Molecular Properties

Compound Name1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione
PubChem CID158361930
Molecular FormulaC70H137N19O18
Molecular Weight1532.98 g/mol
Exact Mass1532.04
IUPAC Name1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione
SMILESCCC(O)Cn1c(=O)n(CC(O)CCCCCCNC)c(=O)n(CC(O)CNCCCCN)c1=O.CCC(O)Cn1c(=O)n(CC(O)CN(C)CCCN(CC)CC)c(=O)n(CC(O)CN(CC)CC)c1=O.CCC(O)Cn1c(=O)n(CC(O)CN2CCNCC2)c(=O)n(CC(O)CN2CCN(C)CC2)c1=O
InChIInChI=1S/C25H50N6O6.C23H46N6O6.C22H41N7O6/c1-7-20(32)17-29-23(35)30(18-21(33)15-26(6)13-12-14-27(8-2)9-3)25(37)31(24(29)36)19-22(34)16-28(10-4)11-5;1-3-18(30)15-27-21(33)28(16-19(31)10-6-4-5-8-12-25-2)23(35)29(22(27)34)17-20(32)14-26-13-9-7-11-24;1-3-17(30)14-27-20(33)28(15-18(31)12-25-6-4-23-5-7-25)22(35)29(21(27)34)16-19(32)13-26-10-8-24(2)9-11-26/h20-22,32-34H,7-19H2,1-6H3;18-20,25-26,30-32H,3-17,24H2,1-2H3;17-19,23,30-32H,3-16H2,1-2H3
InChIKeyGTORQOJOGDOPRF-UHFFFAOYSA-N
XLogP-7.35
TPSA461.62 Ų
H-Bond Donors13
H-Bond Acceptors37
Rotatable Bonds50
Heavy Atoms107
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001532.98
LogP ≤ 5-7.35
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione?
The IUPAC name of 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione (CID 158361930) is 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione.
What is the SMILES notation for 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione?
The canonical SMILES for 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione is CCC(O)Cn1c(=O)n(CC(O)CCCCCCNC)c(=O)n(CC(O)CNCCCCN)c1=O.CCC(O)Cn1c(=O)n(CC(O)CN(C)CCCN(CC)CC)c(=O)n(CC(O)CN(CC)CC)c1=O.CCC(O)Cn1c(=O)n(CC(O)CN2CCNCC2)c(=O)n(CC(O)CN2CCN(C)CC2)c1=O.
What is the InChIKey of 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione?
The InChIKey is GTORQOJOGDOPRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H50N6O6.C23H46N6O6.C22H41N7O6/c1-7-20(32)17-29-23(35)30(18-21(33)15-26(6)13-12-14-27(8-2)9-3)25(37)31(24(29)36)19-22(34)16-28(10-4)11-5;1-3-18(30)15-27-21(33)28(16-19(31)10-6-4-5-8-12-25-2)23(35)29(22(27)34)17-20(32)14-26-13-9-7-11-24;1-3-17(30)14-27-20(33)28(15-18(31)12-25-6-4-23-5-7-25)22(35)29(21(27)34)16-19(32)13-26-10-8-24(2)9-11-26/h20-22,32-34H,7-19H2,1-6H3;18-20,25-26,30-32H,3-17,24H2,1-2H3;17-19,23,30-32H,3-16H2,1-2H3.
What are the key properties of 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione?
1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione has a molecular weight of 1532.98 g/mol, XLogP of -7.35, 50 rotatable bonds, 13 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(4-aminobutylamino)-2-hydroxypropyl]-3-(2-hydroxybutyl)-5-[2-hydroxy-8-(methylamino)octyl]-1,3,5-triazinane-2,4,6-trione;1-[3-(diethylamino)-2-hydroxypropyl]-3-[3-[3-(diethylamino)propyl-methylamino]-2-hydroxypropyl]-5-(2-hydroxybutyl)-1,3,5-triazinane-2,4,6-trione;1-(2-hydroxybutyl)-3-[2-hydroxy-3-(4-methylpiperazin-1-yl)propyl]-5-(2-hydroxy-3-piperazin-1-ylpropyl)-1,3,5-triazinane-2,4,6-trione is sourced from PubChem (CID 158361930), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).